These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 23724912

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report.
    Gulli S, Arrigo C, Bocchino L, Morgante L, Sangari D, Castagna I, Bagnato GF.
    BMC Musculoskelet Disord; 2003 Aug 28; 4():19. PubMed ID: 12946278
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Behcet's refractory uveitis treated successfully by infliximab].
    Mahfoudhi M, Hariz A, Ben Abdelghani K, Turki S, Kheder A.
    Tunis Med; 2014 Jan 28; 92(1):41-2. PubMed ID: 24879172
    [No Abstract] [Full Text] [Related]

  • 8. A case of intestinal Behçet's disease treated with infliximab monotherapy who successfully maintained clinical remission and complete mucosal healing for six years.
    Maruyama Y, Hisamatsu T, Matsuoka K, Naganuma M, Inoue N, Ogata H, Iwao Y, Kanai T, Hibi T.
    Intern Med; 2012 Jan 28; 51(16):2125-9. PubMed ID: 22892489
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Successful use of infliximab in a patient with neuro-Behçet's disease.
    Abalos-Medina GM, Sánchez-Cano D, Ruiz-Villaverde G, Ruiz-Villaverde R, Quirosa Flores S, Raya Alvarez E.
    Int J Rheum Dis; 2009 Sep 28; 12(3):264-6. PubMed ID: 20374357
    [Abstract] [Full Text] [Related]

  • 13. The effect of anti-tumour necrosis factor alpha (infliximab) on sight-threatening uveitis in a patient with Behçet's disease.
    Morris DS, Gavin MP, Sturrock RD.
    Adv Exp Med Biol; 2003 Sep 28; 528():557-9. PubMed ID: 12918763
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antitumor necrosis factor-alpha therapy for early postoperative recurrence of gastrointestinal Behçet's disease: report of a case.
    Byeon JS, Choi EK, Heo NY, Hong SC, Myung SJ, Yang SK, Kim JH, Song JK, Yoo B, Yu CS.
    Dis Colon Rectum; 2007 May 28; 50(5):672-6. PubMed ID: 17216141
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Adalimumab for sight-threatening uveitis in Behçet's disease.
    Mushtaq B, Saeed T, Situnayake RD, Murray PI.
    Eye (Lond); 2007 Jun 28; 21(6):824-5. PubMed ID: 16601736
    [Abstract] [Full Text] [Related]

  • 20. Long-lasting remission of severe Behçet's disease after the end of infliximab therapy.
    Olivieri I, Padula A, Leccese P, D'Angelo S, Giasi V.
    J Rheumatol; 2009 Apr 28; 36(4):855. PubMed ID: 19342728
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.